Gastroenterology society bestows ‘shark tank’ honor to Montreal firm
The Society of American Gastrointestinal and Endoscopic Surgeons has selected Montreal-based FemTherapeutics the winner of its 2025 “shark tank”-style competition at its annual meeting in Long Beach, Calif.
The competition is designed to support clinicians focused on commercializing their innovations through investment capital, according to a March 27 press release sent to Becker’s.
As the winner, FemTherapeutics earns a $30,000 investment from SAGES. Other runner-ups for 2025 include Suture Shield, Qaelon and Evolving Education.
FemTherapeutics aims to provide solutions for common pelvic health conditions, and its flagship product is a personalized intravaginal prosthetic designed to manage pelvic organ prolapse. The company hopes to use the money to expand into incontinence, pelvic pain and maternal health.
